Get startedLog in
    Picture of Spago Nanomedical AB (publ) logo

    SPAGO — Spago Nanomedical AB (publ) News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Spago Nanomedical Submits Application To Start Tumorad Phase I/IIa Study

    Picture of Spago Nanomedical AB (publ) logoSpago Nanomedical AB (publ)
    23/05/2023 08:08
    May 23 (Reuters) - Spago Nanomedical AB (publ)
 SPAGO.ST :
    * HAS SUBMITTED APPLICATION TO START TUMORAD® CLINICAL PHASE
I/IIA
STUDY
    * APPLICATION TO START STUDY HAS BEEN SENT TO ETHICS
COMMITTEE AND
PATIENT ENROLLMENT IS EXPECTED TO START IN SUMMER 2023

Source text for Eikon:  ID:nMFN8x1lmB 
Further company coverage:  SPAGO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Spago Nanomedical AB (publ)

    See all news